News Releases

April 20, 2020

Many biologic treatments are available for controlling symptoms of psoriasis. The treatments have varying purchase costs, dosing amounts and frequency, and real-world use. Therefore, understanding the total costs of these treatments to insurers can be difficult.

April 9, 2020

Experts on our Patient-Centered Outcomes Assessment (PCOA) team collaborated to create this best practices document to help research teams mitigate some of the impacts of COVID-19 on the collection and use of clinical outcome assessment (COA) data.

April 6, 2020

Combination expands offering of real-world data/real-world evidence (RWD/RWE) to the world’s leading pharmaceutical and biotech companies

February 26, 2020

by RTI-HS Health Economists Molly Purser, PhD and Naoko Ronquest, PhD 

February 26, 2020

Healthy women over the age of 75 years might not benefit from continuing breast cancer screening.

January 22, 2020

RTI Health Solutions' parent company, RTI International, has been recognized by Forbes Magazine for its diverse workplace. The annual 2020 list of the ‘Best Employers for Diversity’—released each year by Forbes—ranked RTI #277 out of 500 companies based on a survey of nearly 60,000 employees at...

January 7, 2020

Recurring ear infections in children are not only frustrating and painful–they can also cause serious complications. If antibiotics do not successfully treat an ear infection or if infections continue to occur, a physician may recommend the insertion of ear tubes. Until now that has required the...

December 20, 2019

Answers to key questions about the communication of information for unapproved products as well as unapproved uses of approved products.

November 13, 2019

Pharmacoepidemiology, now in its sixth edition, provides comprehensive guidance available for anyone needing up-to-date information in pharmacoepidemiology.

November 5, 2019

We have conducted a review of publicly available information on scientific advice services offered by HTA bodies

November 5, 2019

Health technology assessments are becoming more influential in countries where payers were traditionally not using value-based pricing methods for pricing negotiations.

November 5, 2019

Respondents need to understand the survey questions if they are going to provide reliable data.

October 28, 2019

New office in Lyon, France, enhances our capabilities in real-world evidence generation 

October 16, 2019

RTI Health Solutions' parent company, RTI International is a 2019 recipient of the Triangle Business Journal’s Leaders in Diversity award. The Leaders in Diversity Awards program, now in its seventh year, recognizes the accomplishments of Triangle businesses, individuals, and nonprofits who have...

August 29, 2019

To leverage ICER’s evaluations as opportunities to communicate the value of health  technologies, we at RTI Health Solutions recommend a proactive, efficient, and strategic approach in preparing for each evaluation.

August 28, 2019

New research co-authored by RTI-HS researchers and published in Patient helps bring greater understanding of patient perspectives in hematologic cancers, particularly acute myeloid leukemia. The researchers analyzed information from a targeted literature review alongside patient-...

August 27, 2019

This study assesses the incidence rates of skeletal related events from the time of castration resistance.

August 23, 2019

Mary Beth was recommended for this honor by a committee of her peers.

August 22, 2019

Can the CIRS-BRAT framework also be used for drug delivery combination products?

August 22, 2019

Valid real-world evidence depends on being able to accurately identify exposures of interest in real-world data.

August 22, 2019

As a result of these findings, a validated coding algorithm updated to ICD-10 codes to identify psychosis associated with dementia is recommended.

August 22, 2019

we conducted an antidepressant drug utilization study in five databases in Denmark, Germany, Spain and Sweden.

August 22, 2019

When using observational data, quantifying the effect of treatment strategies that are sustained over time is not straightforward

August 21, 2019

ICER's influence on pharmaceutical policy is gaining traction. Here are keys to successful collaboration for evaluations.

July 24, 2019

A recent population-based observational study highlights important real-world evidence on treatment patterns, health care burden, occurrence of adverse events, and survival outcomes after a metastatic breast cancer (MBC) diagnosis, in particular among older women with the HR+/HER2–subtype in the...